Skip to content

Michael Lance Middleton, M.D.

NPI 1689635641ActiveIndividual· Nuclear Medicine· Temple, TX

Nuclear Medicine (M.D.) in Temple, Texas, trained at Texas A & M University System, Hsc, College of Medicine (class of 1989). Medicare paid $78,528 for services to 1,083 patients in 2024. Progenics Pharmaceuticals, Inc. reported $33.22 in payments in 2025, mostly food and beverage.

Overview

NPI1689635641
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMar 30, 2006
Last updated in NPPESApr 10, 2020
Certified by providerApr 10, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Nuclear Medicine Primary207U00000XH8258TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nuclear Medicine (TX)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients1,083
Services billed1,251 across 32 procedure codes
Paid by Medicare$78,528

Medicare sources and data years

Education and affiliations

Medical schoolTexas A & M University System, Hsc, College of Medicine
Graduation year1989
Medicare specialtyNuclear Medicine

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$33.22 · 1 payment from 1 company
  • 2024$248.27 · 5 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Progenics Pharmaceuticals, Inc.$33.221

What the 2025 payments were for

  • Food and Beverage$33.22 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine providers in Temple

All Nuclear Medicine providers in Texas →